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A 16-year-old boy presented to an outside institution withprogressive dyspnea for 2 days requiring intubation on
admission. Computed tomography showed a left mainstem
endobronchial lesion and complete collapse of the left lung.
Positron emission tomography showed this to be the only site
of hypermetabolic uptake. Bronchial biopsy showed a non-
keratinizing, moderately differentiated squamous cell carci-
noma. He was then referred to our institution for resection.
Intraoperative lymph node evaluation showed gross and mi-
croscopic involvement of stations 7 and 10L; therefore, a left
pneumonectomy and thoracic lymphadenectomy were per-
formed. Pathology showed a 2.4  2.4  1.3 cm high-grade
squamous cell carcinoma, infiltrating the bronchial cartilage
and extending into the lung parenchyma (Figure 1). The final
pathologic staging was IIIA (T1N2). Because of the predom-
inant squamous histology, he was treated with four cycles of
adjuvant cisplatin and docetaxel followed by radiation ther-
apy and has no evidence of recurrence 34 months after
diagnosis. The tumor was evaluated for nuclear protein of the
testis (NUT) gene rearrangement by fluorescent in situ hy-
bridization and was found to have rearrangement of NUT, but
not of BRD4 (bromodomain-containing protein 4) or BRD3,
and was thus classified as a NUT-variant midline carcinoma.
Consistent with the presence of NUT rearrangement, the
tumor demonstrated speckled nuclear staining with a mono-
clonal antibody to NUT.
NUT midline carcinomas (NMCs) are rare, aggressive
tumors that occur primarily in the thorax and upper aerodi-
gestive tract.1 Only two cases in the literature have occurred
in patients older than 40 years, but the true distribution and
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FIGURE 1. Hematoxylin and eosin staining of squamous
cell carcinoma from the bronchus and lung. Portions of the
tumor appeared to be well-differentiated squamous cell car-
cinoma (arrows), consistent with previous reports of nuclear
protein of the testis (NUT) variants. BRD4-NUT tumors tend
to exhibit less squamous differentiation.
FIGURE 2. Immunohistochemistry using a monoclonal anti-
body against nuclear protein of the testis (NUT). NUT mid-
line carcinomas (NMCs) demonstrate diffuse speckled nu-
clear staining (arrows). This antibody has a sensitivity of 87%
and specificity of 100% for NMCs.4
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prevalence are unclear because of selection bias and under-
sampling.2 Histologically, these tumors are generally poorly
differentiated with varying degrees of squamous differentia-
tion.3 NMCs are defined by the presence of nuclear staining
of NUT by immunohistochemistry (Figure 2)4 and NUT gene
rearrangements detected by fluorescent in situ hybridization
or reverse-transcriptase polymerase chain reaction, the most
common (two thirds of cases) being a balanced t(15;19)
(q13;p13.1) translocation forming a BRD4-NUT fusion gene.2
BRD3 or other uncharacterized partner genes are seen in the
remainder of cases and are termed as NUT variants.3 The
BRD4 protein is involved in the initiation of G1 gene tran-
scription and proliferation, but little is known about NUT
gene function. However, knockdown of BRD4-NUT in NMC
cell lines resulted in irreversible squamous differentiation and
growth arrest—the findings suggest that the role of the
BRD4-NUT oncoprotein is to block differentiation and main-
tain proliferation and may be an attractive therapeutic target
(Figure 3).5 The disease is usually metastatic at presentation,
and prognosis is poor with a median survival of 9 to 10
months.2,4 No standard treatment exists, and the response to
chemotherapy or radiation is dismal.
With the exception of 1 case among the 25 cases
reported thus far,2 our patient is the longest known NMC
survivor without disease. Further, the presence of a NUT
variant translocation is in keeping with suggestions in the
literature that NUT-variant NMCs may, in come cases, be
less aggressive than BRD4-NUT NMCs.3 This case high-
lights the efficacy of complete surgical resection followed by
adjuvant chemoradiotherapy for NMCs, but importantly it
also highlights the need to identify NMCs in patients with
poorly differentiated tumors that do not express lineage-
specific markers and to develop more effective treatment
strategies in this aggressive malignancy.
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FIGURE 3. Dual-color, split-apart fluorescent in situ hybrid-
ization for nuclear protein of the testis (NUT) gene rear-
rangement. The green and red probes flank the 15q14 NUT
break point, and the signals are separated in NUT rearrange-
ments (arrows). The most common NUT rearrangement is
fusion of BRD4 on chromosome 19 to NUT on chromosome
15 forming the BRD4-NUT fusion gene. NUT variants form
fusions with genes other than BRD4, including the highly
homologous gene BRD3.2
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